Schonfeld Strategic Advisors LLC Cure Vac N.V. Transaction History

Schonfeld Strategic Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$3.96 - $6.41 $1.09 Million - $1.76 Million	275,300 New	275,300 $1.16 Million
Q1 2023 May 15, 2023	BUY	$6.38 - $12.5 $151,206 - $296,250	23,700 New	23,700 $165,000
Q3 2022 Nov 14, 2022	BUY	$7.48 - $15.24 $292,468 - $595,884	39,100 New	39,100 $308,000
Q2 2022 Aug 15, 2022	SELL	$13.18 - $19.41 $603,064 - $888,123	-45,756 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$14.73 - $35.25 $673,985 - $1.61 Million	45,756 New	45,756 $897,000
Q4 2021 Feb 14, 2022	SELL	$33.72 - $48.22 $434,920 - $621,941	-12,898 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$49.26 - $74.5 $356,937 - $539,827	7,246 Added 128.2%	12,898 $710,000
Q2 2021 Nov 16, 2021	SELL	$56.91 - $127.53 $52,129 - $116,817	-916 Reduced 13.95%	5,652 $424,000
Q2 2021 Aug 16, 2021	BUY	$56.91 - $127.53 $373,784 - $837,617	6,568 New	6,568 $491,000

12.2M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $769M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.